港股異動 | 中國飛鶴(6186.HK)漲逾7%再創新高 獲南下資金青睞 多機構看好
格隆匯3月11日丨中國飛鶴(6186.HK)今日續漲,暫三日連升累漲逾15%,盤中觸及13.38港元再創上市新高。現報13.32港元,漲7.42%,暫成交7741萬港元,最新總市值1189億港元。中國飛鶴獲納入港股通前日(9日)起生效,同日獲南下資金淨流入3.42億港元,昨日再獲淨流入1.74億港元。興業證券最新發研報指,公司產品力、渠道力、品牌力相輔相成,未來有望在行業集中度提升、政策支持國產的紅利中搶佔更多市場份額,保持高速增長。考慮到其行業龍頭地位和極具性價比的估值,給予“買入”評級。里昂亦料中國飛鶴納入港股通將會令市場對其估值上調,即將公佈的全年業績亦將會成為潛在催化劑。上調目標價至14.7港元,重申“買入”評級,併為中國消費品首選股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.